Log in to your Inderes Free account to see all free content on this page.
Izafe Group
0.251
SEK
+1.62 %
Less than 1K followers
IZAFE B
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
+1.62%
0%
+5.46%
+17.29%
+25.5%
+17.29%
-53.52%
-85.99%
-92.77%
iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions. The company offers products such as Dosell, a pharmaceutical robot, and the SaaS solution Pilloxa, a connected dose bag. The products aim to reduce the risk of incorrect medication. The customers are private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group has its headquarters in Stockholm.
Read moreMarket cap
80.76M SEK
Turnover
5.68K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
28.5.
2025
General meeting '25
30.8.
2025
Interim report Q2'25
3.11.
2025
Interim report Q3'25
All
Press releases
ShowingAll content types
iZafe Group Q1 Interim Report, January-March 2025
March Monthly Update – Continued Growth and Important Progress
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio